Hayk Davtyan

4.9k total citations
55 papers, 2.4k citations indexed

About

Hayk Davtyan is a scholar working on Physiology, Neurology and Molecular Biology. According to data from OpenAlex, Hayk Davtyan has authored 55 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Physiology, 31 papers in Neurology and 17 papers in Molecular Biology. Recurrent topics in Hayk Davtyan's work include Alzheimer's disease research and treatments (38 papers), Neuroinflammation and Neurodegeneration Mechanisms (29 papers) and Computational Drug Discovery Methods (17 papers). Hayk Davtyan is often cited by papers focused on Alzheimer's disease research and treatments (38 papers), Neuroinflammation and Neurodegeneration Mechanisms (29 papers) and Computational Drug Discovery Methods (17 papers). Hayk Davtyan collaborates with scholars based in United States, Australia and Denmark. Hayk Davtyan's co-authors include Mathew Blurton‐Jones, Michael G. Agadjanyan, Anahit Ghochikyan, David H. Cribbs, Irina Petrushina, Jonathan Hasselmann, Morgan Coburn, Christina Tu, Armine Hovakimyan and Amanda McQuade and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuron and Journal of Neuroscience.

In The Last Decade

Hayk Davtyan

54 papers receiving 2.3k citations

Peers

Countries citing papers authored by Hayk Davtyan

Since Specialization

Citations

This map shows the geographic impact of Hayk Davtyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hayk Davtyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hayk Davtyan more than expected).

Fields of papers citing papers by Hayk Davtyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hayk Davtyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hayk Davtyan. The network helps show where Hayk Davtyan may publish in the future.

Co-authorship network of co-authors of Hayk Davtyan

This figure shows the co-authorship network connecting the top 25 collaborators of Hayk Davtyan. A scholar is included among the top collaborators of Hayk Davtyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hayk Davtyan. Hayk Davtyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Human microglia differentially respond to β‐amyloid, tau, and combined Alzheimer's disease pathologies in vivo 2025 ·Alzheimer s & Dementia ·Morgan Coburn, Ghazaleh Eskandari‐Sedighi, Jonathan Hasselmann, Whitney England, Sepideh Kiani Shabestari, Malek Mansour, Amanda McQuade, (unknown), Jean Paul Chadarevian, Christina Tu, Jorge Sá Silva, (unknown), (unknown), Robert C. Spitale, Hayk Davtyan, Mathew Blurton‐Jones	0
2	Harnessing human iPSC-microglia for CNS-wide delivery of disease-modifying proteins 2025 ·Cell stem cell ·Jean Paul Chadarevian, Hayk Davtyan, (unknown), Jasmine Nguyen, (unknown), (unknown), (unknown), (unknown), Malek Mansour, (unknown), (unknown), Christina Tu, Sepideh Kiani Shabestari, (unknown), Ghazaleh Eskandari‐Sedighi, Jonathan Hasselmann, Robert C. Spitale, Mathew Blurton‐Jones	10
3	mRNA Vaccine for Alzheimer’s Disease: Pilot Study 2024 ·Vaccines ·Armine Hovakimyan, (unknown), (unknown), (unknown), Jean Paul Chadarevian, Hayk Davtyan, (unknown), Michael G. Agadjanyan, Anahit Ghochikyan	4
4	Therapeutic potential of human microglia transplantation in a chimeric model of CSF1R-related leukoencephalopathy 2024 ·Neuron ·Jean Paul Chadarevian, Jonathan Hasselmann, (unknown), (unknown), (unknown), (unknown), (unknown), Christina Tu, Jasmine Nguyen, Sepideh Kiani Shabestari, (unknown), Sunil Gandhi, Guojun Bu, David Hume, Clare Pridans, Zbigniew K. Wszołek, Robert C. Spitale, Hayk Davtyan, Mathew Blurton‐Jones	31
5	Microglial APOE3 Christchurch protects neurons from Tau pathology in a human iPSC-based model of Alzheimer’s disease 2024 ·Cell Reports ·Guoqiang Sun, Cheng Wang, (unknown), (unknown), Hayk Davtyan, Mathew Blurton‐Jones, Francisco Lopera, Joseph F. Arboleda‐Velásquez, Yanhong Shi	7
6	ER and SOCE Ca2+ signals are not required for directed cell migration in human iPSC-derived microglia 2024 ·Cell Calcium ·Alberto Granzotto, Amanda McQuade, Jean Paul Chadarevian, Hayk Davtyan, Stefano L. Sensi, Ian Parker, Mathew Blurton‐Jones, Ian F. Smith	2
7	Astrocytic response mediated by the CLU risk allele inhibits OPC proliferation and myelination in a human iPSC model 2023 ·Cell Reports ·Zhenqing Liu, Jianfei Chao, Cheng Wang, Guihua Sun, (unknown), Wei Liu, Xianwei Chen, Li Li, Erpo Tian, Lizhao Feng, Hayk Davtyan, Mathew Blurton‐Jones, Markus Kalkum, Yanhong Shi	18
8	CRISPR generation of CSF1R-G795A human microglia for robust microglia replacement in a chimeric mouse model 2023 ·STAR Protocols ·Jean Paul Chadarevian, Hayk Davtyan, Sonia I Lombroso, F. Chris Bennett, Mathew Blurton‐Jones	5
9	Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer’s disease 2021 ·Molecular Neurodegeneration ·Christel Claes, Emma Danhash, Jonathan Hasselmann, Jean Paul Chadarevian, Sepideh Kiani Shabestari, Whitney England, (unknown), (unknown), Robert C. Spitale, Hayk Davtyan, Mathew Blurton‐Jones	106
10	C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation 2021 ·Neuron ·Deepti Lall, Ileana Lorenzini, (unknown), Shaughn Bell, Thomas E. Mahan, Jason D. Ulrich, Hayk Davtyan, Jessica E. Rexach, A.K.M. Ghulam Muhammad, (unknown), (unknown), (unknown), Junwon Kim, Layla Ghaffari, Jacqueline G. O’Rourke, Daniel H. Geschwind, Mathew Blurton‐Jones, David M. Holtzman, Rita Sattler, Robert H. Baloh	83
11	Induction of Mesoderm and Neural Crest-Derived Pericytes from Human Pluripotent Stem Cells to Study Blood-Brain Barrier Interactions 2019 ·Stem Cell Reports ·(unknown), Duc T. T. Phan, Hayk Davtyan, Vanessa M. Scarfone, (unknown), Mathew Blurton‐Jones, Christopher C.W. Hughes, Matthew A. Inlay	74
12	Development and validation of a simplified method to generate human microglia from pluripotent stem cells 2018 ·Molecular Neurodegeneration ·Amanda McQuade, Morgan Coburn, Christina Tu, Jonathan Hasselmann, Hayk Davtyan, Mathew Blurton‐Jones	233
13	MultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice 2017 ·Vaccine ·Hayk Davtyan, (unknown), Karen Zagorski, Joy Davis, Irina Petrushina, Konstantin Kazarian, David H. Cribbs, Michael G. Agadjanyan, Mathew Blurton‐Jones, Anahit Ghochikyan	19
14	Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency 2017 ·Molecular Neurodegeneration ·Michael G. Agadjanyan, Karen Zagorski, Irina Petrushina, Hayk Davtyan, Konstantin Kazarian, (unknown), Joy Davis, Charles Bon, Mathew Blurton‐Jones, David H. Cribbs, Anahit Ghochikyan	36
15	Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer’s Disease 2017 ·Molecular Therapy ·Irina Petrushina, Hayk Davtyan, Armine Hovakimyan, Arpine Davtyan, Giselle F. Passos, David H. Cribbs, Anahit Ghochikyan, Michael G. Agadjanyan	16
16	BTX AgilePulse<sup>TM</sup> System is an Effective Electroporation Device for Intramuscular and Intradermal Delivery of DNA Vaccine 2014 ·Current Gene Therapy ·Hayk Davtyan, Armine Hovakimyan, Karen Zagorski, Arpine Davtyan, Irina Petrushina, David Agdashian, (unknown), David H. Cribbs, Michael G. Agadjanyan, Anahit Ghochikyan	11
17	Epitope analysis following active immunization with tau proteins reveals immunogens implicated in tau pathogenesis 2014 ·Journal of Neuroinflammation ·(unknown), Hayk Davtyan, Steven B. Housley, Laura J. Blair, Anne T. Gillies, Bryce A. Nordhues, Bo Zhang, Joseph N. Liu, Jason E. Gestwicki, Daniel C. Lee, Marcia N. Gordon, Dave Morgan, Chad A. Dickey	34
18	Primary 4T1 tumor resection provides critical “window of opportunity” for immunotherapy 2013 ·Clinical & Experimental Metastasis ·Anahit Ghochikyan, Arpine Davtyan, Armine Hovakimyan, Hayk Davtyan, (unknown), Alexander Bagaev, Ravshan Ataullakhanov, Edward L. Nelson, Michael G. Agadjanyan	23
19	The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease 2011 ·Journal of Translational Medicine ·Hayk Davtyan, Anahit Ghochikyan, (unknown), Dmitriy Zamarin, Irina Petrushina, Nina Movsesyan, Luis Martínez‐Sobrido, Randy A. Albrecht, Adolfo Garcı́a-Sastre, Michael G. Agadjanyan	14
20	Reducing AD-Like Pathology in 3xTg-AD Mouse Model by DNA Epitope Vaccine — A Novel Immunotherapeutic Strategy 2008 ·PLoS ONE ·Nina Movsesyan, Anahit Ghochikyan, Mikayel Mkrtichyan, Irina Petrushina, Hayk Davtyan, Purevdorj B. Olkhanud, Elizabeth Head, Arya Biragyn, David H. Cribbs, Michael G. Agadjanyan	92

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact